Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_assertion description "[Because the humanized anti-CD20 antibody, rituximab, has antitumor activity in patients with PTLD and stimulates apoptosis in some lymphoid cell lines, we sought to determine whether Bcl-2 antisense treatment potentiates the antitumor effects of rituximab in EBV-associated lymphoproliferative disease in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_assertion evidence source_evidence_literature NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_assertion SIO_000772 12738752 NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_assertion wasDerivedFrom befree-2016 NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_assertion wasGeneratedBy ECO_0000203 NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.
- befree-2016 importedOn "2016-02-19" NP393725.RAhrtdmsNo4OhRzJ9xZIEtnTvj4Vujg5oEPyOv_4RWQiM130_provenance.